BR
Bill Rieflin
Individual
William Bill Rieflin is an experienced biotech executive and investor. Former CEO of NGM Biopharmaceuticals and board member at companies like Lyell Immunopharma and RAPT Therapeutics.
United States · 2+ investments
Biotech
- Headquarters
- United States
- Total Investments
- 2
- Last Investment
- Nov 2021
Overview
Bill Rieflin is an Individual based in United States. It has made 2 investments in Biotech.
Investment History
Sign up to view investment history
Create a free account — 10 credits a month to unlock deal history, amounts, and round details.